Reuters logo
BRIEF-Spark Therapeutics enters into licensing agreement with Genethon
September 20, 2017 / 11:49 AM / a month ago

BRIEF-Spark Therapeutics enters into licensing agreement with Genethon

Sept 20 (Reuters) - Spark Therapeutics Inc

* Spark Therapeutics enters into licensing agreement with Genethon

* Spark Therapeutics Inc - ‍specific genetic target and financial terms of agreement have not been disclosed​

* Spark Therapeutics Inc -co ‍ has option to develop and commercialize any gene therapy that results from licensing agreement​

* Spark Therapeutics Inc - under terms of agreement, Genethon will collaborate with Spark Therapeutics on further preclinical research activities Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below